69339-130 : Zileuton 600 mg Oral Tablet, Multilayer, Extended Release
| NDC: | 69339-130 |
| Labeler: | Dash Pharmaceutical LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Zileuton |
| Dosage Form: | Oral Tablet, Multilayer, Extended Release |
| Application #: | ANDA211390 |
| Rev. Date: |
NDC Package Codes:
- 69339-130-12: 120 TABLET, MULTILAYER, EXTENDED RELEASE IN 1 BOTTLE (69339‑130‑12)
Active Ingredients:
- Zileuton
Dosage Strength:
- 600 mg
Pharmaceutical Classes:
- 5-Lipoxygenase Inhibitors [MoA]
- Decreased Leukotriene Production [PE]
- 5-Lipoxygenase Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 24486-902 Zileuton 600 mg Oral Tablet, Extended Release by Aristos Phamaceuticals, Inc.
- 31722-044 Zileuton 600 mg Oral Tablet, Film Coated, Extended Release by Camber Pharmaceuticals, Inc.
- 49884-723 Zileuton 600 mg Oral Tablet, Multilayer, Extended Release by Par Pharmaceutical, Inc.
- 51407-741 Zileuton 600 mg Oral Tablet, Multilayer, Extended Release by Golden State Medical Supply, Inc.
- 64380-189 Zileuton 600 mg Oral Tablet, Multilayer, Extended Release by Strides Pharma Science Limited
- 64980-206 Zileuton 600 mg Oral Tablet, Extended Release by Rising Pharmaceuticals, Inc.
- 66993-485 Zileuton 600 mg Oral Tablet, Extended Release by Prasco, LLC
- 68180-169 Zileuton 600 1/1 Oral Tablet, Extended Release by Lupin Pharmaceuticals, Inc.
- 72603-246 Zileuton 600 mg Oral Tablet, Film Coated, Extended Release by Northstar Rxllc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69339-127Next: 69339-135 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.